Estimating the prevalence of clinical manganism using a cascaded screening process in a South African manganese smelter

NeuroToxicology

Volumn 30, Issue 6, 2009, Pages 934-940

  Myers, J E ^a   Fine, J ^c   Ormond Brown, D ^d   Fry, J ^e   Thomson, A ^a   Thompson, M L ^a,b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Faculty of Health Sciences   (South Africa)

^d University of the Witwatersrand ^*

^e UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Manganese; Manganism; Neurotoxicity; Parkinsonism

Indexed keywords

MANGANESE;

ARTICLE; BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; HUMAN; INTOXICATION; MOTOR DYSFUNCTION; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NEUROTOXICITY; OCCUPATIONAL HEALTH SERVICE; PARKINSONISM; PATIENT REFERRAL; PERIODIC MEDICAL EXAMINATION; PRIORITY JOURNAL; SCREENING; SENSITIVITY ANALYSIS; SMELTER; SOUTH AFRICA;

ALGORITHMS; CROSS-SECTIONAL STUDIES; ENVIRONMENTAL MONITORING; HUMANS; MANGANESE POISONING; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; OCCUPATIONAL EXPOSURE; PREVALENCE; QUESTIONNAIRES; RISK ASSESSMENT; SOUTH AFRICA;

EID: 71249135140     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2009.08.004     Document Type: Article

References (51)

1. ACGIH threshold limit values for chemical substances and physical agents and biological exposure indices. American Conference of Governmental Industrial Hygienists. Cincinnati, OH (1996)
2. Army Individual Test Battery. Manual of direction and scoring (1944), War Department, Adjunt General's Office, Washington, DC
3. Ashok P.P., Radhakrishnan K., Sridharan R., and Mousa M.E. Epidemiology of Parkinson's disease in Benghazi, North-East Libya. Clin Neurol Neurosurg 88 (1986) 109-113
4. Barr W.B., Chelune G.J., Hermann B.P., Loring D.W., Perrine K., Strauss E., Trenerry M.R., and Westerveld M. The use of figural reproduction tests as measures of nonverbal memory in epilepsy surgery candidates. J Int Neuropsychol Soc 3 (1997) 435-443
5. Bast-Pettersen R., Ellingsen D.G., Hetland S.M., and Thomassen Y. Neuropsychological function in manganese alloy plant workers. Int Arch Occup Environ Health 77 (2004) 277-287
6. Benton A.L., and Hamsher K. Multilingual aphasia examination manual (1989), AJA Associates, Iowa City, Iowa
7. Brown D.S.O., and Nell V. Recovery from diffuse traumatic brain injury in Johannesburg: a concurrent prospective study. Arch Phys Med Rehabil 73 8 (1992) 758-770
8. Bowler R.M., Roels H.A., Nakagawa S., Drezgic M., Diamond E., Park R., Koller W., Bowler R.P., Mergler D., Bouchard M., Smith D., Gwiazda R., and Doty R.L. Dose-effect relationships between manganese exposure and neurological, neuropsychological and pulmonary function in confined space bridge welders. Occup Environ Med 64 (2007) 167-177
9. Burkhard P.R., Delavelle J., Du Pasquier R., and Spahr L. Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degeneration. Arch Neurol 60 (2003) 521-528
10. Calne D.B., Chu N.S., Huang C.C., Lu C.S., and Olanow W. Manganism and idiopathic parkinsonism: similarities and differences. Neurology 44 (1994) 1583-1586
11. Cersosimo M.G., and Koller W.C. The diagnosis of manganese-induced parkinsonism. Neurotoxicology 27 (2006) 340-346
12. Cosnett J.E., and Bill P.L. Parkinson's disease in blacks. Observations on epidemiology in Natal. S Afr Med J 73 (1988) 281-283
13. Couper J. On the effects of black oxide of manganese which inhaled into the lungs. Ann Med Pharm 1 (1837) 2
14. Dotchin C., Msuya O., Kissima J., Massawe J., Mhina A., Moshy A., Aris E., Jusabani A., Whiting D., Masuki G., and Walker R. The prevalence of Parkinson's disease in rural Tanzania. Mov Disord 23 (2008) 1567-1672
15. Ellingsen D.G., Konstantinov R., Bast-Pettersen R., Merkurjeva L., Chashchin M., Thomassen Y., and Chashchin V. A neurobehavioral study of current and former welders exposed to manganese. Neurotoxicology 29 (2008) 48-59
16. Fell J.M., Reynolds A.P., Meadows N., Khan K., Long S.G., Quaghebeur G., Taylor W.J., and Milla P.J. Manganese toxicity in children receiving long-term parenteral nutrition. Lancet 347 (1996) 1218-1221
17. Gitler A.D., Chesi A., Geddie M.L., Strathearn K.E., Hamamichi S., Hill K.J., Caldwell K.A., Caldwell G.A., Cooper A.A., Rochet J.C., and Lindquist S. alpha-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat Genet 41 3 (2009) 316-323
18. Goetz C.G., Fahn S., Martinez-Martin P., Poewe W., Sampaio C., Stebbins G.T., Stern M.B., Tilley B.C., Dodel R., Dubois B., Holloway R., Jankovic J., Kulisevsky J., Lang A.E., Lees A., Leurgans S., LeWitt P.A., Nyenhuis D., Olanow C.W., Rascol O., Schrag A., Teresi J.A., Van Hilten J.J., and LaPelle N. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): process, format, and clinimetric testing plan. Mov Disord 22 (2007) 41-47
19. Goetz C.G., Tilley B.C., Shaftman S.R., Stebbins G.T., Fahn S., Martinez-Martin P., Poewe W., Sampaio C., Stern M.B., Dodel R., Dubois B., Holloway R., Jankovic J., Kulisevsky J., Lang A.E., Lees A., Leurgans S., Lewitt P.A., Nyenhuis D., Olanow C.W., Rascol O., Schrag A., Teresi J.A., van Hilten J.J., and Lapelle N. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23 (2008) 2129-2170
20. Greenhouse A.H. Manganese intoxication in the United States. Trans Am Neurol Assoc 96 (1971) 248-249
21. Huang C.C., Chu N.S., Lu C.S., Chen R.S., and Calne D.B. Long-term progression in chronic manganism: ten years of follow-up. Neurology 50 (1998) 698-700
22. Huang C.C., Chu N.S., Lu C.S., Wang J.D., Tsai J.L., Tzeng J.L., Wolters E.C., and Calne D.B. Chronic manganese intoxication. Arch Neurol 46 (1989) 1104-1106
23. Huang C.C., Lu C.S., Chu N.S., Hochberg F., Lilienfeld D., Olanow W., and Calne D.B. Progression after chronic manganese exposure. Neurology 43 (1993) 1479-1483
24. Jankovic J. Searching for a relationship between manganese and welding and Parkinson's disease. Neurology 64 (2005) 2021-2028
25. Kessler I.I. Epidemiologic studies of Parkinson's disease. II. A hospital-based survey. Am J Epidemiol 95 (1972) 308-318
26. Klove H. Clinical neuropsychology. Med Clin North Am 47 (1963) 1647-1658
27. Lombard A., and Gelfand M. Parkinson's disease in the African. Cent Afr J Med 24 (1978) 5-8
28. Levy L., Aitken R., Holmes P., Joanne Hughes J., Hurley F., Rumsby P.C., et al. Occupational exposure limits: criteria document for manganese (2003), Institute for Environment and Health, United Kingdom
29. Maj M., Janssen R., Satz P., Zaudig M., Starace F., Boor D., Sughondhabirom B., Bing E.G., Luabeya M.K., Ndetei D., et al. The World Health Organization's cross-cultural study on neuropsychiatric aspects of infection with the human immunodeficiency virus 1 (HIV-1). Preparation and pilot phase. Br J Psychiatry 159 (1991) 351-356
30. McInerney-Leo A., Gwinn-Hardy K., and Nussbaum R.L. Prevalence of Parkinson's disease in populations of African ancestry: a review. J Natl Med Assoc 96 (2004) 974-979
31. Myers J.E., teWaterNaude J., Fourie M., Zogoe H.B., Naik I., Theodorou P., Tassel H., Daya A., and Thompson M.L. Nervous system effects of occupational manganese exposure on South African manganese mineworkers. Neurotoxicology 24 (2003) 649-656
32. Myers J.E., Thompson M.L., Ramushu S., Young T., Jeebhay M.F., London L., Esswein E., Renton K., Spies A., Boulle A., Naik I., Iregren A., and Rees D.J. The nervous system effects of occupational exposure on workers in a South African manganese smelter. Neurotoxicology 24 (2003) 885-894
33. NIPR (National Institute of Personnel Research). South African Wechsler Adult Intelligence Scale (1956)
34. Okubadejo N.U., Bower J.H., Rocca W.A., and Maraganore D.M. Parkinson's disease in Africa: a systematic review of epidemiologic and genetic studies. Mov Disord 21 (2006) 2150-2156
35. Olanow C.W. Manganese-induced parkinsonism and Parkinson's disease. Ann N Y Acad Sci 1012 (2004) 209-223
36. Ostiguy C., Asselin P., and Malo S. The emergence of manganese-related health problems in Quebec: an integrated approach to evaluation, diagnosis, management and control. Neurotoxicology 27 (2006) 350-356
37. Paddison R.M., and Griffith R.P. Occurrence of Parkinson's disease in black patients at Charity Hospital in New Orleans. Neurology 24 (1974) 688-690
38. Racette B.A., Tabbal S.D., Jennings D., Good L.M., Perlmutter J.S., and Evanoff B.A. A rapid method for mass screening for parkinsonism. Neurotoxicology 27 (2006) 357-361
39. Richards M., and Chaudhuri K.R. Parkinson's disease in populations of African origin: a review. Neuroepidemiology 15 (1996) 214-221
40. Rey A. L'examen clinique en psychologie (1964), Presses Universitaires de France, Paris
41. Rodier J. Manganese poisoning in Moroccan miners. Br J Ind Med 12 (1955) 21-35
42. Rosenstock H.A., Simons D.G., and Meyer J.S. Chronic manganism. Neurologic and laboratory studies during treatment with levodopa. JAMA 217 (1971) 1354-1358
43. Sadek A.H., Rauch R., and Schulz P.E. Parkinsonism due to manganism in a welder. Int J Toxicol 22 (2003) 393-401
44. SAOEL. South African Occupational Exposure Limits-recommended limits. Hazardous chemical substances regulations, 1995 of the Occupational Health and Safety Act; 1993.
45. Schoenberg B.S., Anderson D.W., and Haerer A.F. Prevalence of Parkinson's disease in the biracial population of Copiah County, Mississippi. Neurology 35 (1985) 841-845
46. Schoenberg B.S., Osuntokun B.O., Adeuja A.O., Bademosi O., Nottidge V., Anderson D.W., and Haerer A.F. Comparison of the prevalence of Parkinson's disease in black populations in the rural United States and in rural Nigeria: door-to-door community studies. Neurology 38 (1988) 645-646
47. Schuler P., Oyanguren H., Maturana V., Valenzuela A., Cruz E., Plaza V., Schmidt E., and Haddad R. Manganese poisoning; clinical & environmental study in a manganese mine. Rev Med Chil 85 (1957) 623-630
48. Selikhova M., Fedoryshyn L., Matviyenko Y., Komnatska I., Kyrylchuk M., Krolicki L., Friedman A., Taylor A., Jager H.R., Lees A., and Sanotsky Y. Parkinsonism and dystonia caused by the illicit use of ephedrone-a longitudinal study. Mov Disord 23 (2008) 2224-2231
49. Smyth L.T., Ruhf R.C., Whitman N.E., and Dugan T. Clinical manganism and exposure to manganese in the production and processing of ferromanganese alloy. J Occup Med 15 (1973) 101-109
50. Stepens A., Logina I., Liguts V., Aldins P., Eksteina I., Platkajis A., Martinsone I., Terauds E., Rozentale B., and Donaghy M. A Parkinsonian syndrome in methcathinone users and the role of manganese. N Engl J Med 358 (2008) 1009-1017
51. Tanaka S., and Lieben J. Manganese poisoning and exposure in Pennsylvania. Arch Environ Health 19 (1969) 674-684